Pharmaceutical Excipients May 2020 Update
This update contains 44 updated monographs, 1 new chapter on excipient selection for inhaled formulations, and 1 new monograph for Silicon Dioxide, Hydrated. Hydrophobic Colloidal Silica has been renamed Silicon Dioxide, Hydrophobic; and Colloidal Silicon Dioxide has been renamed Silicon Dioxide, Anhydrous. The British Pharmacopoeia, European Pharmacopoeia, and USP-NF information has been globally updated.
New chapter: Formulation Considerations for Orally Inhaled Dosage Forms
New monograph: Silicon Dioxide, Hydrated.
Revised monographs: Aliphatic Polyesters; Ammonium phosphate; Ammonium sulfate; Benzethonium Chloride; Benzoic acid; Butylated Hydroxyanisole; Butyl Stearate; Butylated Hydroxytoluene; Calcium Chloride; Calcium Hydroxide; Calcium Silicate; Castor Oil, Hydrogenated; Cetyl Alcohol; Copovidone; Croscarmellose Sodium; Cyclomethicone; Ethylene Glycol Vinyl Alcohol Copolymer; Hexetidine; Hydroxyethyl Cellulose; Hypromellose; Hypromellose Acetate Succinate; Hypromellose Phthalate; Inulin; Isopropyl Alcohol; Linoleic acid; Lysine Hydrochloride; Maleic Acid; Maltodextrin; Maltol; Monoethanolamine; Palm kernel oil; Petrolatum; Polyethylene Oxide; Polyvinyl alcohol; Potassium Benzoate; Shellac; Sodium Ascorbate; Sodium Carbonate; Sodium Sulfite; Sorbitol; Sunflower Oil; Suppository Bases, Hard Fat; Titanium Dioxide; Zinc Oxide.